European Society of Toxicology In Vitro > Uncategorized > Important Notice: Fraudulent Emails Impersonating the ESTIV President and ESTIV Board members
10 March 2026

Important Notice: Fraudulent Emails Impersonating the ESTIV President and ESTIV Board members

We would like to draw your attention to an increased wave of scam attempts targeting ESTIV and many other EU-based societies.

Recently, fraudulent emails have been circulating that impersonate the ESTIV President and ESTIV Board members. These messages are sent from fake email addresses designed to appear legitimate and may ask for urgent assistance, financial support, or bank transfers.

Please note that these messages are not sent by ESTIV and are part of a scam.

Please be assured that ESTIV never requests financial transfers, payments, or personal information via email. Any such message should be considered fraudulent.

For your safety, please:

• Do not respond to suspicious messages
• Do not open unexpected attachments or links
• Do not make any payments based on email requests
• Report any questionable communication to the ESTIV Secretariat immediately

Thank you for your vigilance and cooperation.

ESTIV Secretariat

Related content

ESTIV – ASCCT Webinar: NAMs and Medical Devices – Challenges and Successes

We are thrilled to have Kelly Coleman, PhD, DABT, and Lindsey Borton, MPH, DABT…

2026 ESTIV Applied Training Course – the early-bird registration deadline is approaching!

The deadline for the reduced registration fee is approaching fast — 31 July is the last day! 🚨

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

Silver Sponsor

Communication partners

Memorandum of Understanding